Why did Regeneron buy 23andMe for $256M?
How will US credit downgrade impact markets?
Why is Walmart raising prices due to tariffs?
What led JPMorgan to warn about stagflation?
How did China respond to US Huawei chip restrictions?
Why is Nvidia partnering to scale AI infrastructure?
What does the UK-EU post-Brexit reset entail?
How will Trump’s tax bill affect the economy?
Why is Blink Charging cutting workforce by 20%?
23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction
investors.com/news/technology/23andme-biotech-buyer-regeneron-pharmaceuticals
Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.
The post 23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-05-19 12:55:30.